Overactive Bladder - Results from #2040

Spanish cultural adaptation and psychometrical validation of the Treatment Benefit Scale (TBS) in the symptomatic treatment of overactive bladder - Abstract January 27, 2012

The assessment of quality of life in female Turkish patients with overactive bladder - Abstract January 26, 2012

Overactive bladder syndrome: The social and economic perspective - Abstract January 23, 2012

Muscarinic agonists and antagonists: Effects on the urinary bladder - Abstract January 20, 2012

Role of potassium ion channels in detrusor smooth muscle function and dysfunction January 19, 2012

The influence of melatonin and agomelatine on urodynamic parameters in experimental overactive bladder model - preliminary results January 19, 2012

Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity - Abstract January 19, 2012

Behaviour change to treat overactive bladder syndrome - Abstract January 18, 2012

Repeated botulinum toxin type A injections for refractory overactive bladder: Medium-term outcomes, safety profile, and discontinuation rates - Abstract January 17, 2012

Effects and mechanisms of phosphodiesterase type 5 inhibitors on rats with overactive bladder January 12, 2012

Overactive bladder: Diagnosis and management - Abstract January 9, 2012

Prescription pattern of oxybutynin ER in patients with overactive bladder in real life practice: A multicentre, open-label, prospective observational study - Abstract January 6, 2012

Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey - Abstract January 5, 2012

High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms - Abstract January 4, 2012

Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model December 26, 2011

Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: Pooled analysis of two open-label extension studies - Abstract December 23, 2011

Current management and future perspectives of overactive bladder (OAB) pharmacotherapy - Abstract December 22, 2011

Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder - Abstract December 21, 2011

Behavioral versus drug treatment for overactive bladder in men: The Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial - Abstract December 20, 2011

Characteristics and impact of interrupted sleep in women with overactive bladder - Abstract December 12, 2011

Page 103 of 111

SUFU MyBladder app